Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4434-4438

  Shimada, Akira ^a   Shiota, Goshi ^a   Miyata, Hironori ^a   Kamahora, Toshio ^a   Kawasaki, Hironaka ^a   Shiraki, Kazuo ^a   Hino, Shigeo ^a   Terada, Tadashi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; EIF-2 KINASE; FATTY LIVER; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; RATS; TUMOR CELLS, CULTURED;

EID: 0032189405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hovanessian, A. G. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J. Interferon Res., 9: 641-647, 1989.
2. Galabru, J., and Hovanessian, A. G. Two interferon-induced proteins are involved in the protein kinase complex dependent on double-stranded RNA. Cell, 43: 685-694, 1985.
3. Katze, M. G. Games viruses play: a strategic initiative against the interferon-induced dsRNA activated 68,000 Mr protein kinase. Semin. Virol., 4: 259-268, 1993.
4. Lee, S. B., and Esteban, M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology, 199: 491-496, 1994.
5. Yeung, M. C., Liu, J., and Lau, A. S. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. USA, 93: 12451-12455, 1996.
6. Meurs, E. F., Galabru, J., Barber, G. N., Katze, M. G., and Hovanessian, A. G. Tumor-suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA, 90: 232-236, 1993.
7. Barber, G. N., Wambach, M., Thompson, S., Jagus, R., and Katze, M. G. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol., 15: 3138-3146, 1995.
8. Haines, G. K., Ghadge, G., Thimmappaya, B., and Radosevich, J. A. Expression of the protein kinase p68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 62: 151-158, 1992.
9. Haines, G. K., Ghadge, G. D., Becker, S., Kies, M., Pelzer, H., Thimmappaya, B., and Radosevich, J. A. Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 63: 289-295, 1993.
10. Singh, C., Haines, G. K., Talamonti, M. S., and Radosevich, J. A. Expression of p68 in human colon cancer. Tumor Biol., 16: 281-289, 1995.
11. Haines, G. K., Cajulis, R., Hayden, R., Duda, R., Talamonti, M., and Radosevich, J. A. Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumor Biol., 17: 5-12, 1996.
12. Beretta, L., Gabbay, M., Berger, R., Hanash, S. M., and Sonenberg, N. Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q- associated leukemias. Oncogene, 12: 1593-1596, 1996.
13. Basu, S., Panayiotidis, S. M., Hart, S. M., He, L. Z., Man, A., Hoffbrand, A. V., and Ganeshaguru, K. Role of double-stranded RNA-activated protein kinase in human hematological malignancies. Cancer Res., 57: 943-947, 1997.
14. Kato, N., Yokosuka, O., Hosoda, K., Ito, Y., Ohto, M., and Omata, M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology, 18: 16-20, 1993.
15. Gale, M. J., Jr., Korth, M. J., Tang, N. M., Tan, S. L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., and Katze, M. G. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology, 230: 217-227, 1997.
16. Hiramatsu, N., Hayashi, N., Katayama, K., Mochizuki, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., and Kamada, T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology, 19: 1354-1359, 1994.
17. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
18. Laurent, A. G., Krust, B., Galabru, J., Svab, J., and Hovanessian, A. G. Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. Proc. Natl. Acad. Sci. USA, 82: 4341-4345, 1985.
19. Reuber, M. D. A transplantable bile-secreting hepatocellular carcinoma in the rat. J. Natl. Cancer Inst., 26: 891-899, 1961.
20. Watanabe, H., and Hirai, H. Production of α-fetoprotein by transplantable rat hepatoma. Gann Monogr. Cancer Res., 14: 279-287, 1973.
21. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T., and Sato, J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res., 42: 3858-3863, 1982.
22. Klein, E., Klein, G., Nadkarni, J. S., Nadkarni, J. J., Wigzell, H., and Clifford, P. Surface IgM-κ specificity on a Burkitt lymphoma cell in vitro and in derived culture lines. Cancer Res., 28: 1300-1310, 1968.
23. Matsuzaki, T., Murase, N., Yagihashi, A., Shinozuka, H., Shimizu, Y., Furuya, T., Burrell, N., Iwatsuki, S., and Starzl, T. E. Liver transplantation for diethylnitro-samine-induced hepatocellular carcinoma in rats. Transplant. Proc., 24: 748-751, 1992.
24. Negro, F., Pacchioni, D., Shimizu, Y., Miller, R. H., Bussolati, G., Purcell, R. H., and Borino, F. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc. Natl. Acad. Sci. USA, 89: 2247-2251, 1992.
25. Burke, D. C., Graham, C. F., and Lehman, J. M. Appearance of Interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell, 13: 243-248, 1978.
26. Harada, H., Willison, K., Sakakibara, J., Miyamoto, M., Fujita, T., and Taniguchi, T. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (1RF-2) genes are developmentally regulated. Cell, 63: 303-312, 1990.
27. Resnitzky, D., Yarden, A., Zipori, D., and Kimchi, A. Autocrine β-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell, 46: 31-40, 1986.
28. Nakahara, W. Critique of carcinogenic mechanism. In: F. Homburger (ed.), Progress in Experimental Tumor Research, Vol. 2, pp. 158-202. Basel/New York: S. Karger, 1961.